Working… Menu
Trial record 1 of 18 for:    NKTR-214
Previous Study | Return to List | Next Study

A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors (NKTR-214)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02869295
Recruitment Status : Completed
First Posted : August 16, 2016
Last Update Posted : November 1, 2018
Information provided by (Responsible Party):
Nektar Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 31, 2018
Actual Study Completion Date : October 31, 2018